This episode currently has no reviews.
Submit ReviewIn light of the pandemic, the Life Science Industry is changing. One of the positive developments: The industry is moving faster. The necessity of developing diagnostics, therapeutics, and vaccines against this novel viral threat quickly generates a steep learning curve for all of us.In this episode, I am talking with Peter Llewellyn-Davies, CEO of Apeiron Biologics, how he and his team have set up a clinical phase 2 trial and a 40 million Euro financing round in less than eight weeks.Speaker:Christian Soschner (https://www.linkedin.com/in/christiansoschner/)Peter Llewellyn-Davies (https://www.linkedin.com/in/peterld/)Companies:Apeiron Biologics (https://www.linkedin.com/company/apeiron-biologics/)CS Life Science Invest (https://www.cslifescienceinvest.com/)Be part of our Network:Subscribe here: https://mailchi.mp/e2467061ef75/lsg2g
How to Start a Podcast Guide: The Complete GuideLearn how to plan, record, and launch your podcast with this illustrated guide. Make More with Matt HeslinExplore strategies to thrive financially, build legacy, and enhance life experiences.Listen on: Apple Podcasts Spotify
The LSG2G PartnersExperts in Life ScienceDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Join the Podcast Newsletter: Link
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review